- NRx Pharmaceuticals, Lotus Pharmaceuticals et Alvogen collaborent au dveloppement et la commercialisation sur les marchs mondiaux du [...] Read more »
NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101
- NRx Pharmaceuticals, Lotus Pharmaceuticals, and Alvogen to collaborate on the further development and commercialization of NRX–101 for suicidal treatment–resistant bipolar depression (S–TRBD) for global markets
Read more »
Albireo and Genpharm Announce Agreement to Commercialize Bylvay™ (odevixibat) in Saudi Arabia and the Gulf Region
"" Bylvay is approved in the U.S. and EU as only once–daily drug indicated for patients with PFIC ""
"" PFIC is a life–threatening [...] Read more »
GBT’s Voxelotor is First Sickle Cell Disease Treatment to Receive Promising Innovative Medicine (PIM) Designation in the UK
SOUTH SAN FRANCISCO, Calif. and LONDON, June 14, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT), a biopharmaceutical company dedicated to the discovery, development and [...] Read more »
PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma
RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma , PRA's proprietary technology that allows for the generation of [...] Read more »
PRA Health Sciences expands its response to COVID-19 with pharmacovigilance solutions for authorized vaccines and therapeutics
RALEIGH, N.C., April 21, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) announced today the expansion of its pharmacovigilance solution to offer full post–marketing services for authorized COVID–19 vaccines [...] Read more »
PRA Health Sciences selected by Maryland State Medical Society to supply remote patient monitoring and telehealth services
RALEIGH, N.C. and BALTIMORE, April 13, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) and the Maryland State Medical Society (MedChi) announced today that Care Innovations, a PRA Health Sciences company, was selected by [...] Read more »
PRA’s remote patient monitoring platform selected by Merck KGaA, Darmstadt, Germany to work in combination with its human growth hormone treatment system
RALEIGH, N.C. , April 07, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) announced today that Merck KGaA, Darmstadt, Germany, known in the United States as EMD Serono, selected PRA's remote patient [...] Read more »
PRA’s Center for Rare Diseases Launches Toolkit to Identify and Mitigate Risks to Rare Disease Clinical Programs
RALEIGH, N.C., March 22, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) announced today the launch of its Patient–Centric Trial Development Toolkit, available now to clinical development sponsors focusing on rare [...] Read more »